Is Big Pharma Losing Money by Donating 1,000,000 Pills to the Destitute?

  • Medical
  • Thread starter Loren Booda
  • Start date
In summary, a pharmaceutical company loses $10 million by giving away 1 million pills rather than selling them for $10 each. This cost is mainly due to drug development costs, and the stock price is not affected as much as profits.
  • #1
Loren Booda
3,125
4
How much money does a pharmaceutical company lose by giving away 1,000,000 pills to the destitute rather than selling them at $10 each to those with insurance?
 
Biology news on Phys.org
  • #2
Can't be more than $10,000,000 :biggrin:

Should this be in the math forums?
 
  • #3
I withdraw this thread.
 
  • #4
Actually, it could be quite a bit more. How do you think investors would react to a company reporting that its profits have dropped by millions of dollars? Wouldn't the stock price of the company go down, lowering the value of the company? It seems like the stock market may offer strong incentives not to give away free drugs to the poor.
 
  • #5
Loren Booda said:
How much money does a pharmaceutical company lose by giving away 1,000,000 pills to the destitute rather than selling them at $10 each to those with insurance?

Depends if any of those 1,000,000 recipients have a bad reaction and sue the company.
 
  • #6
Ygggdrasil said:
Actually, it could be quite a bit more. How do you think investors would react to a company reporting that its profits have dropped by millions of dollars? Wouldn't the stock price of the company go down, lowering the value of the company? It seems like the stock market may offer strong incentives not to give away free drugs to the poor.

The stock price is affected by many things, and $10M is not that much when profits are in the hundreds of millions or billions. Even big corporations can be altruistic (and it's good public relations).

EDIT: The big cost is drug development. Once a drug is approved, the manufacturing costs are usually pennies on the dollar. After development costs are recovered, the price per pill is somewhat artificial. Companies can recover the costs of give-aways by raising prices elsewhere if they wish.
 
Last edited:
  • #7
Andy Resnick said:
Depends if any of those 1,000,000 recipients have a bad reaction and sue the company.

It's 1 million pills, not recipients. Whatever the size of the treated population, large pharmaceutical companies maintain full-time legal staffs and retainers. Usually the only real extra costs are if they lose a big case, or much worse, if they have to take a drug off the market (like Merck with Vioxx(c)).
 
Last edited:
  • #8
Loren Booda said:
How much money does a pharmaceutical company lose by giving away 1,000,000 pills to the destitute rather than selling them at $10 each to those with insurance?

if it costs $1 to manufacture 100 pills, then you just spent $10,000 on marketing.

if sales go up because of it, then you profit, and you never would have made a sale to the destitute in the first place (not without government healthcare, at least).
 

FAQ: Is Big Pharma Losing Money by Donating 1,000,000 Pills to the Destitute?

What is "Big Pharma"?

"Big Pharma" is a term used to describe the largest pharmaceutical companies in the world, which often have a significant presence in the global market and hold a large share of the market for prescription drugs.

What does "giving to get" mean in relation to Big Pharma?

"Giving to get" refers to the practice of pharmaceutical companies providing gifts, donations, or other forms of support to healthcare professionals, organizations, or institutions in exchange for potential benefits, such as increased sales or positive publicity.

Is "giving to get" legal?

Generally, the act of "giving to get" is not illegal, as long as it follows legal and ethical guidelines. However, there have been cases where this practice has been deemed unethical, and some pharmaceutical companies have faced legal consequences for their actions.

What are the potential implications of "giving to get" in the healthcare industry?

The practice of "giving to get" can create conflicts of interest between pharmaceutical companies and healthcare professionals, potentially leading to biased prescribing practices and increased healthcare costs. It can also erode public trust in the healthcare system and the pharmaceutical industry.

How can we address the issue of "giving to get" in the pharmaceutical industry?

To address this issue, stricter regulations and guidelines can be put in place to prevent unethical practices. Transparency and disclosure of relationships between pharmaceutical companies and healthcare professionals or organizations can also help to mitigate potential conflicts of interest. Additionally, promoting ethical decision-making and fostering a culture of accountability in the pharmaceutical industry can help prevent "giving to get" practices.

Similar threads

Replies
10
Views
1K
Replies
29
Views
8K
Replies
6
Views
1K
Replies
15
Views
5K
Replies
3
Views
4K
Replies
16
Views
5K
Replies
46
Views
4K
Replies
1
Views
7K
Back
Top